United States
S. 4189
INSULIN Act of 2026
The bill would seek to reduce insulin prices for patients and establish protections to limit how much people pay out of pocket for the medication. It aims to make insulin more affordable and accessible by addressing the high costs that have burdened many Americans who depend on this essential diabetes treatment.[AI-Generated]
Reported by committee 7 August 2026
Record as of 7 August 2026 — the most recent action in the official record. Status can lag; each step below carries its own date.
- 7 August 2026 Reported by committee
What's next: Floor scheduling (leadership decides if and when it gets a vote)
- 7 August 2026 Placed on calendar (Senate)
1 more action
- 22 July 2026 Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
- 25 March 2026 Referred to committee
- 25 March 2026 Introduced in Senate
This path starts where the bill does — its first action in the official record. Routine procedural steps sit in the “more actions” rows above rather than on the main line.
Read the live feed — on the site or in the app Look up S. 4189 on Congress.gov All US bills